NCT01988857View on ClinicalTrials.gov

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

PHASE3CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

February 22, 2014

Primary Completion Date

May 10, 2014

Study Completion Date

May 10, 2014

Conditions
DiphtheriaTetanusAcellular Pertussis
Interventions
BIOLOGICAL

Boostrix™

Single-dose administered intramuscularly in the deltoid region of non-dominant arm.

Trial Locations (1)

084

GSK Investigational Site, Hanoi

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01988857 - Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children | Biotech Hunter | Biotech Hunter